HK1206598A1 - Eprotirome for use in the prevention and or treatment of hair disorders and compositions thereof - Google Patents

Eprotirome for use in the prevention and or treatment of hair disorders and compositions thereof

Info

Publication number
HK1206598A1
HK1206598A1 HK15107075.6A HK15107075A HK1206598A1 HK 1206598 A1 HK1206598 A1 HK 1206598A1 HK 15107075 A HK15107075 A HK 15107075A HK 1206598 A1 HK1206598 A1 HK 1206598A1
Authority
HK
Hong Kong
Prior art keywords
eprotirome
prevention
compositions
treatment
hair disorders
Prior art date
Application number
HK15107075.6A
Other languages
English (en)
Chinese (zh)
Inventor
邁克爾‧澤貝特
烏利齊‧科尼
克里斯托夫‧阿貝爾斯
Original Assignee
Wolff August Gmbh & Co Kg Arzneimittel Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wolff August Gmbh & Co Kg Arzneimittel Dr filed Critical Wolff August Gmbh & Co Kg Arzneimittel Dr
Publication of HK1206598A1 publication Critical patent/HK1206598A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
HK15107075.6A 2012-08-06 2015-07-24 Eprotirome for use in the prevention and or treatment of hair disorders and compositions thereof HK1206598A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261679990P 2012-08-06 2012-08-06
EP12179384.8A EP2695611B1 (en) 2012-08-06 2012-08-06 Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof
PCT/EP2013/066409 WO2014023698A1 (en) 2012-08-06 2013-08-05 Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof

Publications (1)

Publication Number Publication Date
HK1206598A1 true HK1206598A1 (en) 2016-01-15

Family

ID=46963380

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107075.6A HK1206598A1 (en) 2012-08-06 2015-07-24 Eprotirome for use in the prevention and or treatment of hair disorders and compositions thereof

Country Status (16)

Country Link
US (1) US20150182482A1 (xx)
EP (1) EP2695611B1 (xx)
JP (1) JP6125012B2 (xx)
KR (1) KR20150039824A (xx)
CN (1) CN104717964A (xx)
AU (1) AU2013301601B2 (xx)
BR (1) BR112015002540A2 (xx)
CA (1) CA2879847C (xx)
DK (1) DK2695611T3 (xx)
ES (1) ES2528392T3 (xx)
HK (1) HK1206598A1 (xx)
MX (1) MX350125B (xx)
PL (1) PL2695611T3 (xx)
RU (1) RU2015107846A (xx)
SG (1) SG11201500838UA (xx)
WO (1) WO2014023698A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220017917A (ko) 2019-05-08 2022-02-14 알리고스 테라퓨틱스 인코포레이티드 Thr-베타의 조절제 및 이의 사용 방법
CN111110600B (zh) * 2019-12-31 2021-08-06 泉后(深圳)信息技术有限公司 一种头皮净化促生发组合物及其乳液

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2108855T3 (es) * 1992-07-21 1998-01-01 Ciba Geigy Ag Derivados de acido oxamico como agentes hipocolesteremicos.
CA2213481A1 (en) 1995-02-23 1996-08-29 Life Medical Sciences, Inc. Compositions and methods for enhancing the growth of hair and restoring hair color
MXPA01012496A (es) 1999-06-01 2002-07-02 Univ Texas Southwestern Med Ct Compuestos de biarilo.
US6646005B1 (en) 1999-06-01 2003-11-11 The University Of Texas Southwestern Medical Center Method of treating hair loss using sulfonyl thyromimetic compounds
EP1185231A1 (en) * 1999-06-01 2002-03-13 The Procter & Gamble Company Method of treating hair loss using diphenylmethane derivatives
WO2000072920A1 (en) 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Substituted biaryl ether compounds
CA2374262A1 (en) 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Method of treating hair loss
JP2003500432A (ja) * 1999-06-01 2003-01-07 ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター ジフェニルエーテル誘導体を用いて脱毛症を処置する方法
PL201790B1 (pl) 2000-02-17 2009-05-29 Bristol Myers Squibb Co Anilinopochodny ligand dla receptora tarczycy, jego zastosowanie i kompozycja farmaceutyczna
AP2002002634A0 (en) 2000-03-31 2002-09-30 Pfizer Prod Inc Malonamic Acids And Derivatives Thereof As Thyroid Receptor Ligands.
DK1262177T3 (da) 2001-05-31 2006-11-20 Pfizer Prod Inc Medicinsk brug af thyromimetiske forbindelser til behandling af hårtab og kompositioner
EP1297833B1 (en) 2001-09-26 2005-12-21 Pfizer Products Inc. Indole carboxylic acids as thyroid receptor ligands
US6806381B2 (en) 2001-11-02 2004-10-19 Bristol-Myers Squibb Company Process for the preparation of aniline-derived thyroid receptor ligands
US7230031B2 (en) 2002-01-30 2007-06-12 Kissei Pharmaceutical Co., Ltd. Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
JP4810151B2 (ja) 2005-07-22 2011-11-09 出光興産株式会社 イネの育苗時期に発生する病害に対する防除剤
JP4858443B2 (ja) 2005-07-22 2012-01-18 株式会社ニコン デジタルカメラ
GB0606201D0 (en) 2006-03-28 2006-05-10 Karobio Ab Improved crytalline material
KR20090025367A (ko) 2006-06-28 2009-03-10 가부시키가이샤산와카가쿠켄큐쇼 신규 6-5계 이환식 복소환 유도체 및 그 의약용도
GB0724478D0 (en) 2007-12-14 2008-01-30 Karobio Ab Pharmaceutical compositions
GB0725214D0 (en) 2007-12-24 2008-02-06 Karobio Ab Pharmaceutical compounds
JP2009155261A (ja) 2007-12-26 2009-07-16 Sanwa Kagaku Kenkyusho Co Ltd 新規インドール誘導体及びその医薬用途
EP2609910A1 (en) * 2011-12-30 2013-07-03 Deva Holding Anonim Sirketi Formulations of eprotirome

Also Published As

Publication number Publication date
WO2014023698A1 (en) 2014-02-13
CA2879847C (en) 2017-10-03
BR112015002540A2 (pt) 2017-12-12
CN104717964A (zh) 2015-06-17
KR20150039824A (ko) 2015-04-13
ES2528392T3 (es) 2015-02-09
PL2695611T3 (pl) 2015-03-31
MX350125B (es) 2017-08-28
RU2015107846A (ru) 2016-09-27
US20150182482A1 (en) 2015-07-02
AU2013301601B2 (en) 2016-09-01
CA2879847A1 (en) 2014-02-13
EP2695611B1 (en) 2014-10-01
DK2695611T3 (en) 2015-01-05
JP6125012B2 (ja) 2017-05-10
SG11201500838UA (en) 2015-03-30
MX2015001670A (es) 2015-04-10
AU2013301601A1 (en) 2015-02-05
JP2015524458A (ja) 2015-08-24
EP2695611A1 (en) 2014-02-12

Similar Documents

Publication Publication Date Title
HK1249861A1 (zh) 治療血紅蛋白病的組合物和方法
HRP20181364T8 (hr) Aminotriazolopiridin, namijenjen upotrebi u liječenju upale, te njegovi farmacetski pripravci
IL239355A0 (en) Compositions of gamma-hydroxybutyrate and their use in the treatment of disorders
IL225239A0 (en) Compounds for the treatment of acne and related diseases
ZA201408055B (en) Compositions and methods for the treatment of local pain
LT2854910T (lt) Ceramido lygiai infekcijos gydymo ir prevencijos metu
EP2897621A4 (en) COMPOUNDS AND COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES, PAIN AND FEVER, SKIN DISEASES, CANCER AND PRECULTURAL INJURIES
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
HK1211221A1 (en) Formulations for the treatment and prevention of obesity
IL233875A (en) Preparation and use for the treatment of anal fissures
HK1207289A1 (en) Composition for prevention of vasoactivity in the treatment of blood loss and anemia
HK1200353A1 (zh) 用於預防或治療情感障礙的 -取代的苯丙酰胺或苯丙烯酰胺
HK1206598A1 (en) Eprotirome for use in the prevention and or treatment of hair disorders and compositions thereof